Sequella, Inc.
Records under this name other than patents Sequella, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,128,941 | Assay for Detecting Tuberculosis in Nonhuman Primates Formerly held In force · High confidence | In force | High confidence | |
| US 8,202,910 | Compositions and methods for treatment of infectious disease Term ended Term ended Jul 3, 2026 · From the USPTO record | Term ended | Term ended Jul 3, 2026 | From the USPTO record |
| US 7,652,039 | Methods of use and compositions for the diagnosis and treatment of infectious disease Term ended Term ended May 17, 2025 · From the USPTO record | Term ended | Term ended May 17, 2025 | From the USPTO record |
| US 8,198,303 | Methods of use and compositions for the diagnosis and treatment of infectious diseases Term ended Term ended Jun 12, 2023 · From the USPTO record | Term ended | Term ended Jun 12, 2023 | From the USPTO record |
| US 7,919,234 | Methods and compositions for determining the pathogenic status of infectious agents Lapsed on the fee record Ended Apr 5, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 5, 2023 | From the USPTO record |
| US 7,456,222 | Anti Tubercular Drug: Compositions and Methods Term ended Term ended Jul 11, 2022 · Medium confidence | Term ended | Term ended Jul 11, 2022 | Medium confidence |
| US 7,842,729 | Anti Tubercular Drug: Compositions and Methods Term ended Term ended May 17, 2022 · Medium confidence | Term ended | Term ended May 17, 2022 | Medium confidence |
| US 8,268,894 | Compositions and Methods for the Treatment of Infectious Diseases Term ended Term ended May 17, 2022 · Medium confidence | Term ended | Term ended May 17, 2022 | Medium confidence |
| US 8,501,400 | Methods and compositions for determining the pathogenic status of infectious agents Lapsed on the fee record Ended Aug 6, 2021 · From the USPTO record | Lapsed on the fee record | Ended Aug 6, 2021 | From the USPTO record |
| US 6,472,384 | Antimicrobial Compounds Term ended Term ended Jul 9, 2019 · High confidence | Term ended | Term ended Jul 9, 2019 | High confidence |